Please read and agree to the
terms and conditions
of this site.
I agree
Funding Series
/tech
Clear filters and search
Format
photo
Tags
biotech
financing
3
×
funding
life sciences
national blog main
cancer
clinical trials
orbimed
seattle blog main
venture capital
abbvie
acerta pharma
adage capital management
adverse events
alexandria venture investments
antibody drugs
antibody-drug conjugate
arix
arix bioscience
astrazeneca
bispecific antibodies
boston
boston blog main
bostonvc
bristol meyers squibb
calistoga pharmaceuticals
celgene
citadel
clayton knox
colt ventures
cormorant asset management
dave johnson
decheng capital
devices
drug conjugates
farallon
foresite capital
funds and accounts advised by t. rowe price associates
gilead sciences
her2
What
targeting
3
×
advance
based
biotech
cancer
drug
years
adds
antibody
avoid
biopolymers
boosts
boston’s
building
capabilities
ceo
closing
dangerous
dave
developing
diego
drugs
effects
france
immunotherapies
johnson
kept
kipps
known
manufacturing
nearly
physician
platform
proprietary
reseacher
ror
san
scene
series
silverback
Language
unset
Current search:
financing
×
targeting
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}